Breaking News Instant updates and real-time market news.

UNH

UnitedHealth

$266.71

2.11 (0.80%)

, HON

Honeywell

$168.81

-6 (-3.43%)

20:25
07/17/19
07/17
20:25
07/17/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include UnitedHealth (UNH), consensus $3.45... Honeywell (HON), consensus $2.08... Philip Morris (PM), consensus $1.32... Union Pacific (UNP), consensus $2.14... Danaher (DHR), consensus $1.16... Morgan Stanley (MS), consensus $1.14... Blackstone (BX), consensus 50c... BB&T Corp (BBT), consensus $1.07... SunTrust Banks (STI), consensus $1.45... Nucor (NUE), consensus $1.32... Genuine Parts (GPC), consensus $1.65... Ally Financial (ALLY), consensus 88c.

UNH

UnitedHealth

$266.71

2.11 (0.80%)

HON

Honeywell

$168.81

-6 (-3.43%)

PM

Philip Morris

$81.06

-0.49 (-0.60%)

UNP

Union Pacific

$164.05

-11.05 (-6.31%)

DHR

Danaher

$139.60

-0.22 (-0.16%)

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

BX

Blackstone

$45.27

-0.555 (-1.21%)

BBT

BB&T

$49.68

0.04 (0.08%)

STI

SunTrust

$63.99

0.08 (0.13%)

NUE

Nucor

$54.71

-0.87 (-1.57%)

GPC

Genuine Parts

$102.27

-3.07 (-2.91%)

ALLY

Ally Financial

$31.44

-0.26 (-0.82%)

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

  • 20

    Aug

  • 21

    Aug

  • 26

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 26

    Sep

  • 07

    Nov

UNH UnitedHealth
$266.71

2.11 (0.80%)

07/16/19
PIPR
07/16/19
NO CHANGE
PIPR
Overweight
UnitedHealth coverage decision positive for Neuronetics, says Piper Jaffray
UnitedHealth (UNH) recently issued a coverage decision stating that theta burst TMS has been deemed "unproven and not medically necessary," which will make obtaining reimbursement from the insurer more difficult in the future for theta burst providers, Piper Jaffray analyst Matt O'Brien tells investors in a research note. This would specifically impact MagVentures, which has been mentioned frequently as a key competitor to monitor for Neuronetics (STIM), adds the analyst. The analyst says that with no changes to the reimbursement pathway for Neuronetics in the coverage update, he views the news as incrementally positive for the company as it competes in the theta-burst stimulation category for major depressive disorder patients. O'Brien reiterates an Overweight rating on Neuronetics and continues to view the name as his favorite small cap idea.
07/15/19
GSCO
07/15/19
DOWNGRADE
Target $85
GSCO
Sell
Goldman Sachs downgrades Quest Diagnostics to Sell, cuts target to $85
Goldman Sachs analyst Patrick Donnelly downgraded Quest Diagnostics (DGX) to Sell from Neutral and lowered his price target for the shares to $85 from $90. The company remains in a flat- to low-single-digit organic growth environment which will constrain operating profit and free cash flow growth, Donnelly tells investors in a research note. Further, the analyst sees "little reason for optimism" in the near term around the UnitedHealth (UNH) Preferred Lab Network. The incentive structure to further narrow lab use is uncertain and "in-network" status is most likely to continue to dominate volume flow, says Donnelly. He sees downside risk to Quest's to out-year estimates "as the lab business struggles to grow organically."
07/15/19
CLVD
07/15/19
NO CHANGE
CLVD
UnitedHealth continues to gain market share, says Cleveland Research
Cleveland Research analyst Steve Willoughby said earlier today that his recent work indicates UnitedHealth continues to gain share across both the UHC and OptumRx businesses. Feedback on the upcoming Medicare Advantage Annual Election Period points to UnitedHealth likely being best positioned to lead the market in membership growth, Willoughby wrote in a research note. The analyst's Q2, 2019 and 2020 estimates are ahead of consensus and keeps a Buy rating on UnitedHealth shares.
07/11/19
SPHN
07/11/19
NO CHANGE
SPHN
Stephens raises targets for Anthem, Cigna, peers on HHS rebate rule withdrawal
Following press reports that the White House has withdrawn its proposed rule to eliminate drug rebates in Medicare/Medicaid outside point of sale, Stephens analyst Scott Fidel raised his price targets on a number of managed care stocks, calling the elimination of this key near-term overhang a "material positive event" for the MCO and PBM group. He raised his price target on Anthem (ANTM) to $350 from $335, upped his target on Cigna (CI) to $240 from $225, increased his target on Humana (HUM) to $320 from $300 and raised his target on UnitedHealth (UNH) to $290 from $270. Fidel keeps Overweight ratings on all four of those stocks. He also raised his target on Magellan Health (MGLN) to $74 from $70, though he keeps an Equal Weight rating on that stock, citing the company's softer fundamentals.
HON Honeywell
$168.81

-6 (-3.43%)

07/16/19
GSCO
07/16/19
NO CHANGE
GSCO
Goldman does not see favorable setup for Americas Multi-Industry into Q2
Goldman Sachs analyst Joe Ritchie does not see the setup as favorable for the Americas Multi-Industry sector into the Q2 reporting season with the exception of Buy-rated Honeywell (HON). The analyst says fiscal 2020 consensus expectations are too high for a third of the companies he covers while the setup is tough for the second half of 2019 as comps are only easier for five out of 27 stocks "at a time when growth is decelerating." As a result, Ritchie downgraded three cyclical stocks to Sell, namely Cognex (CGNX) and Parker-Hannifin (PH) from Neutral and Kennametal (KMT) double downgraded from Buy. He also upgraded Timken to Buy from Neutral as he believes expectations are more appropriately calibrated and its relative valuation is "compelling."
06/20/19
RBCM
06/20/19
INITIATION
Target $80
RBCM
Sector Perform
DuPont initiated with a Sector Perform at RBC Capital
RBC Capital analyst Arun Viswanathan initiated DuPont (DD) with a Sector Perform rating and a price target of $80 after its completed spin-offs, saying the current valuation asks investors for a "leap of faith" with multiples comparable to multi-industry peers like 3M (MMM) and Honeywell (HON). The analyst notes that although the company's improvements are "tangible", he also sees its prospects as more dependent on the macro conditions. Given the softer auto and smartphone demand in China, Viswanathan prefers to have "greater confidence" in DuPont performance before assigning a higher multiple.
04/22/19
DBAB
04/22/19
NO CHANGE
Target $187
DBAB
Buy
Honeywell price target raised to $187 from $174 at Deutsche Bank
Deutsche Bank analyst Nicole DeBlase raised her price target for Honeywell to $187 from $174 saying the company reported another "strong" quarter. The analyst believes Honeywell will be viewed as the best Q1 release in the space when all peers are done reporting. In a post-earnings research note titled "Simply The Best," DeBlase keeps a Buy rating on the shares.
04/23/19
FBCO
04/23/19
NO CHANGE
Target $185
FBCO
Outperform
Honeywell price target raised to $185 from $170 at Credit Suisse
Credit Suisse analyst John Walsh raised his price target for Honeywell to $185 from $170 after the company posted "strong" organic sales growth of 8%, with strength across all segments. The analyst reiterates an Outperform rating on the shares.
PM Philip Morris
$81.06

-0.49 (-0.60%)

07/01/19
PIPR
07/01/19
NO CHANGE
Target $100
PIPR
Overweight
Philip Morris checks in Japan show iQOS momentum, says Piper Jaffray
Piper Jaffray analyst Michael Lavery says his recent channel checks in Japan suggest "good momentum" for iQOS. The analyst continues to believe iQOS is the most compelling heated tobacco product and he maintains an Overweight rating on Philip Morris shares with a $100 price target.
05/28/19
SBSH
05/28/19
NO CHANGE
SBSH
Cigarette data from Nielsen 'dire,' industry data also 'very bad,' says Citi
Citi analyst Adam Spielman noted that Nielsen reported earlier today that cigarette industry volumes fell 11.2% in the four weeks ended May 18, noting that shares of Altria (MO), British American Tobacco (BTI) and Imperial (IMBBY) all fell following the "dire" data. Volumes in MSAi, the industry database that he regards as much more reliable than Nielsen, were down 6.4% in the same period, which Spielman said "is still a very bad figure, but it is a lot, lot better than the Nielsen one." Looking ahead, the analyst said he expects "gradually less bad" volumes in Nielsen in the rest of the year, though he noted that Altria has said it expects industry volumes to fall about 4%-5% this year and he forecasts a decline of about 6%. In late afternoon trading, Altria shares are down 4.5%, British American has declined over 4% and Philip Morris (PM) is down 5%.
06/19/19
WELS
06/19/19
NO CHANGE
Target $100
WELS
Outperform
Philip Morris recent selloff 'unjustified,' says Wells Fargo
Wells Fargo analyst Bonnie Herzog reiterates her bullish call on Philip Morris and believes the recent selloff in the stock is "unjustified." The analyst sees this as an opportunity for long-term investors to enter or build positions in what she believes is one of the "most attractive CPG stocks" in terms of growth prospects and yield characteristics. Herzog reiterates an Outperform rating and $100 price target on the shares.
07/16/19
WELS
07/16/19
NO CHANGE
WELS
Wells says Nielsen restatement could be positive for Monster, tobacco stocks
Wells Fargo analyst Bonnie Herzog noted that Nielsen (NLSN) just announced that it will restate data to address serious issues with its calculation methodology in the convenience store channel related to projections it applied to independent c-stores. The restated data, to be released on August 20, is expected to improve cigarette and energy drink trends and she views this as a positive for tobacco stocks and Monster Beverage (MNST). Publicly traded companies in the tobacco space include Altria Group (MO), British American Tobacco (BTI) and Philip Morris (PM).
UNP Union Pacific
$164.05

-11.05 (-6.31%)

06/17/19
06/17/19
DOWNGRADE
Target $177

Market Perform
Union Pacific downgraded to Market Perform at Bernstein
As previously reported, Bernstein analyst David Vernon downgraded Union Pacific to Market Perform from Outperform and lowered its price target on the shares to $177 from $190. The analyst believes is not worth playing in a down freight market as rail stocks do not work in a down truck market.
07/17/19
CSND
07/17/19
DOWNGRADE
CSND
Hold
Cascend downgrades four rails on weakening intermodal traffic
Cascend Securities downgraded four names in the rail space, CSX (CSX), Norfolk Southern (NSC), Kansas City Southern (KSU), and Union Pacific (UNP), to Hold after three years at Buy. Intermodal traffic is down since February, and it doesn't look like a "pause," Cascend tells investors in a research note. Further, industrial equipment imports into the U.S. has suddenly declined sharply, adds the firm, which notes that CSX last night called the economic backdrop "puzzling."
07/17/19
CKCP
07/17/19
DOWNGRADE
CKCP
Union Pacific downgraded to Hold from Buy at Cascend Securities
07/10/19
GSCO
07/10/19
INITIATION
Target $198
GSCO
Buy
Union Pacific initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Jordan Alliger started Union Pacific with a Buy rating and $198 price target. The analyst thinks shares of Union Pacific still offer upside in the context of its recent implementation of PSR. The company should generate near the high end of rail operating rail improvement in 2019-2021, Alliger tells investors in a research note.
DHR Danaher
$139.60

-0.22 (-0.16%)

06/11/19
06/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. FormFactor (FORM) initiated with a Buy at Needham. 2. Victory Capital (VCTR) initiated with a Perform at Oppenheimer. 3. Agilent (A) initiated with an Overweight at Piper Jaffray. 4. Danaher (DHR) initiated with a Neutral at Piper Jaffray. 5. Amag Pharmaceuticals (AMAG) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/19
BREN
05/15/19
INITIATION
Target $96
BREN
Buy
Fortive initiated with a Buy at Berenberg
Berenberg analyst Andrew Buscaglia initiated Fortive (FTV) with a Buy rating and $96 price target, stating that he believes the company will prove to be the leader of the next generation of multi-industry industrials and the stock "provides a second chance" to own a stock like Danaher (DHR), from which Fortive was spun-out. Buscaglia also thinks synergies are just beginning from Fortive's portfolio transformation, he noted.
05/30/19
WOLF
05/30/19
INITIATION
Target $172
WOLF
Outperform
Danaher initiated with an Outperform at Wolfe Research
Wolfe Research initiated Danaher with an Outperform and $172 price target.
06/11/19
PIPR
06/11/19
INITIATION
Target $148
PIPR
Neutral
Danaher initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk started Danaher with a Neutral rating and $148 price target. The company's 10% valuation premium to the peer median is justified given its portfolio alignment with the dental spin-off and recent acquisitions, Quirk tells investors in a research note. However, the valuation keeps him on the sidelines.
MS Morgan Stanley
$43.78

-0.63 (-1.42%)

07/17/19
BMOC
07/17/19
NO CHANGE
Target $273
BMOC
Market Perform
Goldman Sachs price target raised to $273 from $260 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Goldman Sachs (GS) to $273 after its "equities-driven" beat on the top line in Q2 and rolled out valuation. The analyst maintains his Market Perform rating however, saying he continues to prefer Morgan Stanley (MS) to Goldman Sachs given the lower valuation of the former and continued risks around the 1MDB issues of the latter.
07/12/19
SBSH
07/12/19
UPGRADE
SBSH
Buy
Morgan Stanley upgraded to Buy from Neutral at Citi
Citi analyst Keith Horowitz upgraded Morgan Stanley to Buy from Neutral.
07/12/19
07/12/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Buy from Neutral at Goldman Sachs with analyst Judy Hong saying the valuations in the tobacco sector are trading at a 10-year trough in spite of the "more accommodating" macro backdrop for Consumer Staples that includes a late cycle and lower yields. 2. Focus Financial (FOCS) upgraded to Outperform from Market Perform at Keefe Bruyette. 3. Deutsche Bank (DB) upgraded to Neutral from Sell at UBS. 4. Morgan Stanley (MS) upgraded to Buy from Neutral at Citi. 5. Snap (SNAP) upgraded to Buy from Neutral at Goldman Sachs with analyst Heath Terry saying the company's new Android app, the launch of Snap Games, and new viral lenses should accelerator user growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/12/19
SBSH
07/12/19
NO CHANGE
SBSH
Morgan Stanley upgrade, Wells downgrade among Citi's bank changes
Citi analyst Keith Horowitz made seven rating changes in the U.S. Banks space after updating his estimates and target prices for a new base case rate forecast that more closely reflects the forward curve. This includes two interest rate cuts in 2019 and 2020. The analyst's terminal yield curve assumptions to Fed Funds is 1.75%. The lower rate assumptions led him to lower his normal return on tangible equity estimates ~100 basis points on average. Following these changes, Horowitz upgraded Morgan Stanley (MS) to Buy from Neutral), downgraded Comerica (CMA), Northern Trust (NTRS), and M&T Bank (MTB) to Sell from Neutral, and downgraded Wells Fargo (WFC), Citizens Financial (CFG), and Fifth Third (FITB) to Neutral from Buy.
BX Blackstone
$45.27

-0.555 (-1.21%)

07/09/19
MSCO
07/09/19
NO CHANGE
MSCO
Morgan Stanley sees C-corp conversion announcement coming from Carlyle
Morgan Stanley analyst Michael Cyprys said he recommends owning Carlyle Group (CG) shares into the quarter, as he believes the company will announce plans to convert to a C-corporation along with its upcoming report, "albeit with a delayed effective date" to allow time for the complex underlying tax impact analysis. He thinks a conversion could bring greater clarity and visibility into targets, which could increase long only interest in the stock, Cyprys tells investors. In his broader preview of the earnings season for the Asset Manager group, the analyst noted that he lowered his Q2 EPS estimates by about 4% on average, cutting his estimates for Traditionals by 0.5%, for Alts by 11.5% and for Market Structure companies by 1.6%.
07/08/19
JMPS
07/08/19
DOWNGRADE
JMPS
Market Perform
Blackstone downgraded to Market Perform from Outperform at JMP Securities
JMP Securities analyst Devin Ryan downgraded Blackstone to Market Perform from Outperform, stating that his conversations with investors lead him to believe that many generalist money managers have been underweight Financials for some time and that this accelerated when the yield curve inverted earlier in the year. While he remains bullish on fundamentals, Ryan thinks the risk/reward in some of the more recent outperformers, such as Blackstone, is becoming more balanced, he said.
06/27/19
SBSH
06/27/19
NO CHANGE
SBSH
Blackstone removed from U.S. Focus List at Citi
Citi analyst William Katz removed Blackstone (BX) from his firm's U.S. Focus List following the stock's 40% year-to-date appreciation. The analyst sees greater upside elsewhere but believes Blackstone's fundraising and business diversification "remains best-in-class." value. Apollo Global (APO) now sits atop the analyst's ranks given the company's "incrementally more attractive risk/reward paired with favorable C-Corp catalysts."
07/15/19
BOFA
07/15/19
INITIATION
Target $70
BOFA
Neutral
Thomson Reuters reinstated with a Neutral at BofA/Merrill
BofA Merrill Lynch analyst Gary Bisbee reinstated coverage of Thomson Reuters (TRI) with a Neutral rating and $70 price target, telling investors that the company's sale of a 55% stake in Refinitiv to Blackstone (BX) is a win-win and that the "new" Thomson is a "cleaner, faster growth story." However, he also sees this being largely priced in after a run-up in the stock over the last twelve months.
BBT BB&T
$49.68

0.04 (0.08%)

03/26/19
03/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Bed Bath & Beyond (BBBY) upgraded to Strong Buy from Market Perform at Raymond James , to Hold from Sell at Loop Capital, and to Sector Weight from Underweight at KeyBanc. 2. BB&T (BBT) upgraded to Buy from Hold at Deutsche Bank with analyst Matt O'Connor saying after meeting with CEO of SunTrust (STI), he remains positive on the merger and the combined stock. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at William Blair with analyst Y. Katherine Xu citing expectations that the company's cystic fibrosis franchise will continue dominating after Proteostasis (PTI) reported disappointing triplet data. 4. Allegiant Travel (ALGT) upgraded to Outperform from Neutral at Macquarie with analyst Susan Donofrio citing her meetings with its management last week. 5. TransAlta (TAC) upgraded to Buy from Hold at TD Securities with analyst John Mould saying Brookfield Renewable Partners (BEP) $750M investment in TransAlta improves the company's financial flexibility, accelerates its ability to return capital to shareholders and advance the coal-to-gas conversion. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/19
RAJA
04/04/19
DOWNGRADE
RAJA
Market Perform
BB&T downgraded to Market Perform from Outperform at Raymond James
04/04/19
04/04/19
UPGRADE
Target $44

Strong Buy
Synovus upgraded to Strong Buy at Raymond James
As previously reported, Raymond James analyst David Lon upgraded Synovus (SNV) to Strong Buy from Outperform, with a $44 price target. The analyst cited the recent pullback in the stock and what he sees as an outsized opportunity for market share gain stemming from the recently announced BB&T (BBT)-SunTrust (STI) mega merger.
04/04/19
RAJA
04/04/19
DOWNGRADE
RAJA
Market Perform
BB&T downgraded to Market Perform on near-term noise at Raymond James
As previously reported, Raymond James analyst David Lon downgraded BB&T (BBT) to Market Perform from Outperform and reducing his EPS estimates. The analyst cited the nearer-term noise surrounding its merger with SunTrust (STI) and his view that BB&T shares are unlikely to outperform until there is greater clarity on when the deal will actually close and its ability to retain key talent with the combined company's footprint. Moreover, larger acquirer stock prices generally haven't reacted favorably over the past few years, he contends.
STI SunTrust
$63.99

0.08 (0.13%)

03/11/19
MSCO
03/11/19
DOWNGRADE
Target $73
MSCO
Equal Weight
Morgan Stanley downgrades SunTrust to Equal Weight as focus shifts to execution
As previously reported, Morgan Stanley analyst Betsy Graseck downgraded SunTrust (STI) to Equal Weight from Overweight as she believes it to be prudent to "take some chips off the table" following the year-to-date outperformance driven by news of its merger of equals with BB&T (BBT). The focus of investors will shift from the merger to execution and while she thinks the $1.6B in cost savings seem attainable at 12% of the combined company's expenses, she also expects it will take two years before net expense savings convincingly accelerate, she tells investors. She lowered her price target on SunTrust shares to $73 from $80 and lowered her price target on BB&T shares to $56 from $62.
03/26/19
DBAB
03/26/19
UPGRADE
Target $53
DBAB
Buy
BB&T upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Matt O'Connor last night upgraded BB&T (BBT) to Buy from Hold with an unchanged price target of $53. After meeting with CEO of SunTrust (STI), the analyst remains positive on the merger and the combined stock. He upgraded BB&T to be consistent with his Buy rating on SunTrust. He notes that BB&T shares are down 11% since the deal was announced on February 7.
NUE Nucor
$54.71

-0.87 (-1.57%)

05/31/19
BOFA
05/31/19
DOWNGRADE
Target $50
BOFA
Underperform
Nucor downgraded to Underperform from Buy at BofA/Merrill
BofA Merrill Lynch analyst Timna Tanners double downgraded Nucor, to Underperform from Buy, to incorporate a lower near-term forecast for prices, especially for sheet and rebar, and a lower 2021-2022 forecast given expectations for a looming glut in steel. Nucor produces three of the products that Tanners thinks will be most hurt by new supply: sheet, rebar, and plate. The analyst lowered the price target on Nucor shares to $50 from $68.
05/30/19
DBAB
05/30/19
DOWNGRADE
Target $53
DBAB
Hold
Nucor downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Chris Terry downgraded Nucor to Hold from Buy and lowered his price target for the shares to $53 from $65. The analyst made rating changes in the Steel and Service Centers space after reviewing his firm's pricing forecasts. Terry says that even though stocks have been already been under pressure, he's cautious on the near term for the Steel and Service Centers sub-sector. The analyst moved his recommendations to a more negative stance and sees value elsewhere, especially in precious metals.
06/26/19
JEFF
06/26/19
NO CHANGE
JEFF
Nucor flat rolled price increase likely to help sentiment, says Jefferies
After Nucor (NUE) announced a $40/t flat rolled price increase yesterday, which was the first increase since February, Jefferies analyst Martin Englert said he thinks peers are likely to follow. While the increase may not immediately raise prices, it is a move in the right direction that aids more positive sector sentiment, Englert tell investors. The analyst, who advises investors to increase exposure to steel stocks, names Nucor, Steel Dynamics (STLD), Cleveland-Cliffs (CLF) and Commercial Metals (CMC) as his top U.S. picks Other publicly traded companies in the steel space include AK Steel (AKS), ArcelorMittal (MT), TimkenSteel (TMST) and U.S. Steel (X).
05/31/19
05/31/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Mallinckrodt (MNK) downgraded to Neutral from Overweight at Piper Jaffray with analyst David Amsellem stating last week's developments regarding Acthar in the Medicaid setting, along with as much as a $600M Centers for Medicare & Medicaid Services-related liability, "essentially blew" his prior investment thesis to "smithereens." 2. Nucor (NUE) downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners incorporating a lower near-term forecast for prices, especially for sheet and rebar, and a lower 2021-2022 forecast given expectations for a looming glut in steel. 3. J.Jill (JILL) downgraded to Hold from Buy at Deutsche Bank with analyst Lorraine Hutchinson stating that she expects the stock's multiple to contract due to the company's slower growth. 4. Nutanix (NTNX) downgraded to Neutral from Overweight at Piper Jaffray with analyst Andrew Nowinski citing the company's "continued execution issues," which he attributes partially to increasing competition. 5. Zuora (ZUO) downgraded to Buy from Strong Buy at Needham with analyst Scott Berg saying that the stock could be "dead money" for the next 1-2 quarters, noting that the sales issues are more concerning than the product issues and may require a change in sales leadership. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GPC Genuine Parts
$102.27

-3.07 (-2.91%)

03/25/19
JPMS
03/25/19
NO CHANGE
Target $398
JPMS
Overweight
O'Reilly Automotive added to Analyst Focus List at JPMorgan
JPMorgan analyst Christopher Horvers added O'Reilly Automotive (ORLY) to his firm's Analyst Focus List following his "weather deep dive." 2019's winter has been "solid" but not as good as 2018 due to snowfall levels, Horvers tells investors in a research note. He points out that autoparts demand is "quite sensitive" to extreme weather trends. The analyst believes the 2019 winter benefits O'Reilly the most among the "big 4," which also includes Advance Auto Parts (AAP), AutoZone (AZO) and Genuine Parts (GPC). Horvers keeps an Overweight rating on O'Reilly Automotive with a $398 price target.
07/15/19
JPMS
07/15/19
NO CHANGE
Target $104
JPMS
Neutral
Genuine Parts price target lowered to $104 from $114 at JPMorgan
JPMorgan analyst Christopher Horvers lowered his price target for Genuine Parts to $104 from $114 ahead of the company's Q2 results on Wednesday. The analyst sees the stock as fully valued in the near term. The interest rate backdrop makes the stock's 2.9% yield attractive, but this is offset by underlying softness in the company's industrials division and moderation in automotive, Horvers tells investors in a research note. Further, he sees some downside risk to consensus estimates. The analyst keeps a Neutral rating on Genuine Parts.
05/30/19
SPHN
05/30/19
INITIATION
Target $114
SPHN
Overweight
Genuine Parts initiated with an Overweight at Stephens
Stephens analyst Daniel Imbro started Genuine Parts with an Overweight rating and a $114 price target, citing his view that the company's core U.S. auto business is well positioned and that is also has a strong market position in Europe. He also thinks that after a recent pullback the stock's current valuation gives investors an attractive entry point.
07/11/19
GSCO
07/11/19
INITIATION
Target $107
GSCO
Neutral
Genuine Parts initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Kate McShane started Genuine Parts with a Neutral rating and $107 price target. The analyst sees a balanced risk/reward at current share levels.
ALLY Ally Financial
$31.44

-0.26 (-0.82%)

04/02/19
MSCO
04/02/19
NO CHANGE
Target $30
MSCO
Equal Weight
Ally buyback approval significantly higher than estimated, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck noted that Fed CCAR instructions released on February 5 exempted banks with assets between $100B-$250B from the 2019 stress test, which meant that Ally Financial did not need to wait for Fed approval in June to announced that its board authorized the repurchase of up to $1.25B in common stock for 3Q19-2Q20. This $1.25B authorization is significantly higher than her $560M estimate, said Graseck, who raised her 2020 EPS estimate for Ally by 14c, or 3.5%, in response to the news. Graseck keeps an Equal Weight rating on Ally shares.
04/02/19
SBSH
04/02/19
NO CHANGE
SBSH
Buy
Ally Financial buyback plan above forecast, says Citi
Citi analyst Arren Cyganovich says Ally Financial's new repurchase plan of up to $1.25B is above his forecast of $900M. The analyst is "somewhat surprised" by the 25% increase in the authorization with the implementation of the current expected credit loss model beginning on January 1, 2020, but he sees it as a sign of confidence that the company "can withstand the initial phased-in capital hit to book value." Cyganovich has a Buy rating on Ally Financial.
07/03/19
SBSH
07/03/19
NO CHANGE
Target $37
SBSH
Buy
Ally Financial price target raised to $37 from $35 at Citi
Citi analyst Arren Cyganovich raised his price target for Ally Financial to $37 from $35 and reiterates a Buy rating on the shares after traveling with the company's CFO Jennifer LaClair. The analyst came away with renewed confidence in Ally's positioning and stock trajectory. He sees possible net interest margin expansion if Fed lowers target interest rates, a path toward more "bank-like" returns on tangible equity, and earnings growth. Cyganovich believes Ally Financial is one of the most attractive stocks in his group.
04/22/19
BMOC
04/22/19
NO CHANGE
Target $39
BMOC
Market Perform
Ally Financial price target raised to $39 from $34 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Ally Financial to $39 after its Q1 earnings beat. The analyst is keeping his Market Perform rating however, saying he is concerned about the company's capital, with 9.3% B3CET1 ratio as the "lowest among its cohort". The analyst add that he prefers other opportunities among his coverage of large-cap banks, specialty lenders, and financial technology stocks.

TODAY'S FREE FLY STORIES

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$19.94

0.16 (0.81%)

17:57
08/16/19
08/16
17:57
08/16/19
17:57
Hot Stocks
Breaking Hot Stocks news story on Wendy's »

Trian Fund lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BRY

Berry Petroleum

$8.59

0.39 (4.76%)

17:54
08/16/19
08/16
17:54
08/16/19
17:54
Syndicate
Breaking Syndicate news story on Berry Petroleum »

Berry Petroleum files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSWI

CSW Industrials

$70.20

1.92 (2.81%)

17:52
08/16/19
08/16
17:52
08/16/19
17:52
Hot Stocks
CSW Industrials CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$3.03

0.135 (4.66%)

17:49
08/16/19
08/16
17:49
08/16/19
17:49
Hot Stocks
Oasis Petroleum CEO buys 30K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EE

El Paso Electric

$66.41

0.005 (0.01%)

17:45
08/16/19
08/16
17:45
08/16/19
17:45
Hot Stocks
El Paso Electric director Wertheimer sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HON

Honeywell

$165.07

2.81 (1.73%)

17:42
08/16/19
08/16
17:42
08/16/19
17:42
Hot Stocks
Honeywell CEO sells 7.1K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBRX

Moleculin Biotech

$1.08

0.01 (0.93%)

17:37
08/16/19
08/16
17:37
08/16/19
17:37
Earnings
Moleculin Biotech reports Q2 EPS (3c), two estimates (10c) »

CFO Jonathan Foster…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIVE

Viveve

$0.13

0.0046 (3.59%)

17:35
08/16/19
08/16
17:35
08/16/19
17:35
Syndicate
Breaking Syndicate news story on Viveve »

Viveve files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGO

Perrigo

$46.21

0.535 (1.17%)

17:30
08/16/19
08/16
17:30
08/16/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Perrigo »

Starboard lowers Perrigo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

UAL

United Continental

$82.96

1.36 (1.67%)

17:28
08/16/19
08/16
17:28
08/16/19
17:28
Hot Stocks
United Continental director Shapiro buys 10K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 05

    Sep

  • 23

    Sep

MBIO

Mustang Bio

$3.88

0.19 (5.15%)

17:26
08/16/19
08/16
17:26
08/16/19
17:26
Syndicate
Breaking Syndicate news story on Mustang Bio »

Mustang Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

BCLI

BrainStorm

$3.63

0.055 (1.54%)

17:24
08/16/19
08/16
17:24
08/16/19
17:24
Syndicate
Breaking Syndicate news story on BrainStorm »

BrainStorm files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLK

Westlake Chemical

$61.27

0.66 (1.09%)

17:15
08/16/19
08/16
17:15
08/16/19
17:15
Hot Stocks
Westlake Chemical raises quarterly dividend by 5% to 26.25c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIG

GigCapital

$10.30

(0.00%)

17:10
08/16/19
08/16
17:10
08/16/19
17:10
Hot Stocks
GigCapital receives noncompliance notice from NYSE »

GigCapital announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.